Results
1
1 companies
ALTEOGEN
Market Cap: ₩16.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩308,500.00
7D
2.7%
1Y
-26.9%
